Skip to main content
SpringerLink
Log in

Gestational Diabetes

  • Chapter
  • First Online:
Endocrinology and Diabetes

  • 1247 Accesses

Abstract

Gestational diabetes (GDM) is a common complication of pregnancy, reflecting inadequate beta cell compensation in the face of pregnancy-related insulin resistance. The prevalence and severity of GDM reflects the population rate of Type 2 diabetes in women in the reproductive age group and is generally increasing with the advance of the global obesity epidemic. This article reviews the diagnosis of GDM, the importance of specific underlying diagnoses, and traditional and alternative approaches to therapy. Evidence regarding the benefits of GDM treatment is summarized and perinatal management reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hadden DR, Hillebrand B. The first recorded case of diabetic pregnancy (Bennewitz HG, 1824, University of Berlin). Diabetologia. 1989;32(8):625.

    CAS  PubMed  Google Scholar 

  2. Miller HC. The effect of diabetic and prediabetic pregnancies on the fetus and newborn infant. J Pediatr. 1946;29(4):455–61.

    CAS  PubMed  Google Scholar 

  3. Carrington ER, Shuman CR, Reardon HS. Evaluation of the prediabetic state during pregnancy. Obstet Gynecol. 1957;9(6):664–9.

    CAS  PubMed  Google Scholar 

  4. O’Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278–85.

    PubMed  Google Scholar 

  5. Freinkel N. Banting lecture 1980. Of pregnancy and progeny. Diabetes. 1980;29(12):1023–35.

    CAS  PubMed  Google Scholar 

  6. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.

    PubMed  Google Scholar 

  7. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.

    PubMed  Google Scholar 

  8. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: WHO Press; 2013.

    Google Scholar 

  9. Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131 Suppl 3:S173–211.

    PubMed  Google Scholar 

  10. Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35:780–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Pedersen J, Bojsen-Moller B, Poulsen H. Blood sugar in newborn infants of diabetic mothers. Acta Endocrinol. 1954;15(1):33–52.

    CAS  Google Scholar 

  12. Sacks DA, Greenspoon JS, Abu-Fadil S, Henry HM, Wolde-Tsadik G, Yao JF. Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. Am J Obstet Gynecol. 1995;172(2 Pt 1):607–14.

    CAS  PubMed  Google Scholar 

  13. Omori Y, Jovanovic L. Proposal for the reconsideration of the definition of gestational diabetes. Diabetes Care. 2005;28(10):2592–3.

    PubMed  Google Scholar 

  14. van Leeuwen M, Louwerse MD, Opmeer BC, Limpens J, Serlie MJ, Reitsma JB, et al. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG. 2012;119(4):393–401.

    PubMed  Google Scholar 

  15. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115(3):485–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19(3):268–70.

    CAS  PubMed  Google Scholar 

  17. Wucher H, Lepercq J, Carette C, Colas C, Dubois-Laforgue D, Gautier JF, et al. Poor prognosis of pregnancy in women with autoimmune type 1 diabetes mellitus masquerading as gestational diabetes. Diabetes Metab. 2011;37(1):47–51.

    CAS  PubMed  Google Scholar 

  18. Nilsson C, Ursing D, Torn C, Aberg A, Landin-Olsson M. Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes. Diabetes Care. 2007;30(8):1968–71.

    PubMed  Google Scholar 

  19. Rauh-Hain JA, Rana S, Tamez H, Wang A, Cohen B, Cohen A, et al. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med. 2009;22(4):293–9.

    PubMed  Google Scholar 

  20. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21(2):103–13.

    CAS  PubMed  Google Scholar 

  21. Hernandez TL, Friedman JE, Van Pelt RE, Barbour LA. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care. 2011;34(7):1660–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. American Diabetes A. Standards of medical care in diabetes--2011. Diabetes Care. 2011;34 Suppl 1:S11–61.

    Google Scholar 

  23. Simmons D, McElduff A, McIntyre HD, Elrishi M. Gestational diabetes mellitus: NICE for the U.S.? A comparison of the American Diabetes Association and the American College of Obstetricians and Gynecologists guidelines with the U.K. National Institute for Health and Clinical Excellence guidelines. Diabetes Care. 2010;33(1):34–7.

    CAS  PubMed  Google Scholar 

  24. Seshiah V, Das AK, Balaji V, Joshi SR, Parikh MN, Gupta S, et al. Gestational diabetes mellitus--guidelines. J Assoc Physicians India. 2006;54:622–8.

    CAS  PubMed  Google Scholar 

  25. Canadian Diabetes A, Dietitians of C, Diabete Q, Ordre professionnel des dietetistes du Q. Recommendations for nutrition best practice in the management of gestational diabetes mellitus. Executive summary (1). Can J Diet Pract Res. 2006;67(4):206–8.

    Google Scholar 

  26. Canadian Diabetes Association. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32:S168–S81.

    Google Scholar 

  27. Nankervis A, McIntyre HD, Moses RG, Ross GP, Callaway LK. Testing for gestational diabetes mellitus in Australia. Diabetes Care. 2013;36(5):e64.

    PubMed  PubMed Central  Google Scholar 

  28. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–86.

    CAS  PubMed  Google Scholar 

  29. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–48.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Reader D, Splett P, Gunderson EP, Diabetes C, Education Dietetic Practice G. Impact of gestational diabetes mellitus nutrition practice guidelines implemented by registered dietitians on pregnancy outcomes. J Am Diet Assoc. 2006;106(9):1426–33.

    PubMed  Google Scholar 

  31. Moses RG, Brand-Miller JC. The use of a low glycaemic index diet in pregnancy: an evolving treatment paradigm. Diabetes Res Clin Pract. 2011;91(1):13–4.

    PubMed  Google Scholar 

  32. Louie JC, Markovic TP, Perera N, Foote D, Petocz P, Ross GP, et al. A randomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care. 2011;34(11):2341–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. McElduff A, Moses RG. Insulin therapy in pregnancy. Endocrinol Metab Clin North Am. 2012;41(1):161–73.

    CAS  PubMed  Google Scholar 

  34. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134–8.

    CAS  PubMed  Google Scholar 

  35. Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010;203(5):457 e1–9.

    Google Scholar 

  36. Cheng YW, Chung JH, Block-Kurbisch I, Inturrisi M, Caughey AB. Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J Matern Fetal Neonatal Med. 2012;25(4):379–84.

    CAS  PubMed  Google Scholar 

  37. Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102.

    PubMed  PubMed Central  Google Scholar 

  38. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–15.

    CAS  PubMed  Google Scholar 

  39. Moore LE, Briery CM, Clokey D, Martin RW, Williford NJ, Bofill JA, et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med. 2007;52(11):1011–5.

    CAS  PubMed  Google Scholar 

  40. Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T, et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG. 2011;118(7):880–5.

    CAS  PubMed  Google Scholar 

  41. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):524–9.

    CAS  PubMed  Google Scholar 

  42. De Leo V, Musacchio MC, Piomboni P, Di Sabatino A, Morgante G. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):63–6.

    PubMed  Google Scholar 

  43. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril. 2002;77(3):520–5.

    CAS  PubMed  Google Scholar 

  44. Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogoy K, Kleggetveit O, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab. 2010;95(12):E448–55.

    CAS  PubMed  Google Scholar 

  45. Silva JC, Fachin DR, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med. 2012;40(3):225–8.

    CAS  PubMed  Google Scholar 

  46. Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol. 2010;115(1):55–9.

    CAS  PubMed  Google Scholar 

  47. Silva JC, Pacheco C, Bizato J, de Souza BV, Ribeiro TE, Bertini AM. Metformin compared with glyburide for the management of gestational diabetes. Int J Gynaecol Obstet. 2010;111(1):37–40.

    CAS  PubMed  Google Scholar 

  48. Ogunyemi DA, Fong A, Rad S, Fong S, Kjos SL. Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med. 2011;28(8):976–86.

    CAS  PubMed  Google Scholar 

  49. Simmons D, Walters BNJ, Rowan JA, McIntyre HD. Metformin therapy and diabetes in pregnancy. Med J Aust. 2004;180(9):462–4.

    PubMed  Google Scholar 

  50. Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet Med. 2011;28(9):1082–7.

    CAS  PubMed  Google Scholar 

  51. Gandhi P, Bustani R, Madhuvrata P, Farrell T. Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact? Eur J Obstet Gynecol Reprod Biol. 2012;160(2):147–50.

    CAS  PubMed  Google Scholar 

  52. Cygalova LH, Hofman J, Ceckova M, Staud F. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. J Pharmacol Exp Ther. 2009;331(3):1118–25.

    CAS  PubMed  Google Scholar 

  53. Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Hankins GD, Ahmed MS. Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol. 2010;202(4):383 e1–7.

    Google Scholar 

  54. Schwartz RA, Rosenn B, Aleksa K, Koren G. Glyburide transport across the human placenta. Obstet Gynecol. 2015;125(3):583–8.

    CAS  PubMed  Google Scholar 

  55. Charles B, Norris R, Xiao X, Hague W. Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit. 2006;28(1):67–72.

    CAS  PubMed  Google Scholar 

  56. Kovo M, Haroutiunian S, Feldman N, Hoffman A, Glezerman M. Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. Eur J Obstet Gynecol Reprod Biol. 2008;136(1):29–33.

    CAS  PubMed  Google Scholar 

  57. Kovo M, Kogman N, Ovadia O, Nakash I, Golan A, Hoffman A. Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model. Prenat Diagn. 2008;28(6):544–8.

    CAS  PubMed  Google Scholar 

  58. Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34(10):2279–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Glueck CJ, Salehi M, Sieve L, Wang P. Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome. J Pediatr. 2006;148(5):628–32.

    CAS  PubMed  Google Scholar 

  60. Weiss PA, Hofmann HM, Winter RR, Lichtenegger W, Purstner P, Haas J. Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels. Arch Gynecol. 1986;239(2):81–91.

    CAS  PubMed  Google Scholar 

  61. Schaefer-Graf UM, Kjos SL, Buhling KJ, Henrich W, Brauer M, Heinze T, et al. Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes. Diabet Med. 2003;20(5):349–54.

    CAS  PubMed  Google Scholar 

  62. Buchanan TA, Kjos SL, Montoro MN, Wu PY, Madrilejo NG, Gonzalez M, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. 1994;17(4):275–83.

    CAS  PubMed  Google Scholar 

  63. Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care. 2001;24(11):1904–10.

    CAS  PubMed  Google Scholar 

  64. Kjos SL, Schaefer-Graf UM. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care. 2007;30 Suppl 2:S200–5.

    PubMed  Google Scholar 

  65. Schaefer-Graf UM, Kjos SL, Fauzan OH, Buhling KJ, Siebert G, Buhrer C, et al. A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care. 2004;27(2):297–302.

    PubMed  Google Scholar 

  66. Bonomo M, Cetin I, Pisoni MP, Faden D, Mion E, Taricco E, et al. Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes Metab. 2004;30(3):237–44.

    CAS  PubMed  Google Scholar 

  67. Drury MI, Stronge JM, Foley ME, MacDonald DW. Pregnancy in the diabetic patient: timing and mode of delivery. Obstet Gynecol. 1983;62(3):279–82.

    CAS  PubMed  Google Scholar 

  68. Rasmussen MJ, Firth R, Foley M, Stronge JM. The timing of delivery in diabetic pregnancy: a 10-year review. Aust N Z J Obstet Gynaecol. 1992;32(4):313–7.

    CAS  PubMed  Google Scholar 

  69. Landon MB, Langer O, Gabbe SG, Schick C, Brustman L. Fetal surveillance in pregnancies complicated by insulin-dependent diabetes mellitus. Am J Obstet Gynecol. 1992;167(3):617–21.

    CAS  PubMed  Google Scholar 

  70. Gabbe S, Hill L, Schmidt L, Schulkin J. Management of diabetes by obstetrician-gynecologists. Obstet Gynecol. 1998;91(5 Pt 1):643–7.

    CAS  PubMed  Google Scholar 

  71. Boulvain M, Stan C, Irion O. Elective delivery in diabetic pregnant women. Cochrane Database Syst Rev. 2001;(2):CD001997.

    Google Scholar 

  72. Kjos SL, Henry OA, Montoro M, Buchanan TA, Mestman JH. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol. 1993;169(3):611–5.

    CAS  PubMed  Google Scholar 

  73. Witkop CT, Neale D, Wilson LM, Bass EB, Nicholson WK. Active compared with expectant delivery management in women with gestational diabetes: a systematic review. Obstet Gynecol. 2009;113(1):206–17.

    PubMed  Google Scholar 

  74. Gherman RB, Ouzounian JG, Miller DA, Kwok L, Goodwin TM. Spontaneous vaginal delivery: a risk factor for Erb’s palsy? Am J Obstet Gynecol. 1998;178(3):423–7.

    CAS  PubMed  Google Scholar 

  75. Hod M, Bar J, Peled Y, Fried S, Katz I, Itzhak M, et al. Antepartum management protocol. Timing and mode of delivery in gestational diabetes. Diabetes Care. 1998;21 Suppl 2:B113–7.

    CAS  PubMed  Google Scholar 

  76. Crume TL, Ogden LG, Mayer-Davis EJ, Hamman RF, Norris JM, Bischoff KJ, et al. The impact of neonatal breast-feeding on growth trajectories of youth exposed and unexposed to diabetes in utero: the EPOCH Study. Int J Obes (Lond). 2012;36(4):529–34. https://doi.org/10.1038/ijo.2011.254. Epub 2 Jan 31.

    Article  CAS  Google Scholar 

  77. O’Reilly M, Avalos G, Dennedy MC, O’Sullivan EP, Dunne FP. Breast-feeding is associated with reduced postpartum maternal glucose intolerance after gestational diabetes. Ir Med J. 2012;105(5 Suppl):31–6.

    PubMed  Google Scholar 

  78. Gunderson EP, Hedderson MM, Chiang V, Crites Y, Walton D, Azevedo RA, et al. Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care. 2012;35(1):50–6. Epub 2011 Oct 19.

    CAS  PubMed  Google Scholar 

  79. Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. Gestational diabetes mellitus--management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust. 1998;169(2):93–7.

    CAS  PubMed  Google Scholar 

  80. Oats JJ, McIntyre HD. Revision of guidelines for the management of gestational diabetes mellitus. Med J Aust. 2004;181(6):342.

    PubMed  Google Scholar 

  81. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–8.

    PubMed  Google Scholar 

  82. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9.

    CAS  PubMed  Google Scholar 

  83. Bentley-Lewis R. Gestational diabetes mellitus: an opportunity of a lifetime. Lancet. 2009;373(9677):1738–40.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetric Medicine, Mater Health Services and Mater Clinical Unit, University of Queensland, South Brisbane, QLD, Australia

    H. David McIntyre

  2. School of Population and Global Health, University of Melbourne, Carlton, VIC, Australia

    Jeremy J. N. Oats

Authors
  1. H. David McIntyre
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeremy J. N. Oats
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. David McIntyre .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Agamenon Magalhães Hospital, University of Pernambuco Medical School, Recife, Pernambuco, Brazil

    Francisco Bandeira

  2. Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA

    Hossein Gharib

  3. School of Medicine, University of Pernambuco, Recife, Brazil

    Luiz Griz

  4. School of Medicine, University of Maranhao, Sao Luis, Brazil

    Manuel Faria

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McIntyre, H.D., Oats, J.J.N. (2022). Gestational Diabetes. In: Bandeira, F., Gharib, H., Griz, L., Faria, M. (eds) Endocrinology and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-030-90684-9_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-90684-9_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-90683-2

  • Online ISBN: 978-3-030-90684-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation